US equities |
SPCX $171.09 ▲+0.00% MU $1,063.96 ▲+0.00% NVDA $238.90 ▲+0.00% META $741.90 ▲+0.00% AMD $631.75 ▲+0.00% AMZN $251.40 ▲+0.00% INTC $116.19 ▲+0.00% SNDK $1,704.16 ▲+0.00%
FinancialContent

Articles published by Adaptive Biotechnologies

< Previous 1 2 Next >
News headline image
Adaptive Biotechnologies Highlights Role of Highly Sensitive MRD Testing in New International Myeloma Society Definition of Cure
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies Announces Update to NCCN Guidelines® for Multiple Myeloma, Strengthening MRD Testing Recommendations and Specifically Referencing clonoSEQ®
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies Reports Second Quarter 2026 Financial Results
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies to Report Second Quarter 2026 Financial Results on July 29, 2026
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies Reports First Quarter 2026 Financial Results
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT PFE
News headline image
Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies Reports Third Quarter 2025 Financial Results
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies to Report Third Quarter 2025 Financial Results on November 5, 2025
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies Reports Second Quarter 2025 Financial Results
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ® MRD Testing into OncoEMR®
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
News headline image
Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
From Adaptive Biotechnologies
Via GlobeNewswire
Tickers ADPT
< Previous 1 2 Next >